No Data
No Data
Lantheus to Present Additional Clinical Data From Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
Theranostics Market Report 2024-2029 and Company Analysis of Bayer, Curium Pharma, GE Healthcare, Lantheus, Novartis, Siemens Healthineers and Telix Pharmaceuticals
Insider Sale: Director Gerard Ber Sells 15,500 Shares of Lantheus Holdings Inc (LNTH)
Strong Outlook for Lantheus: Buy Rating Amid Positive CMS Rule Changes and Promising Alzheimer's PET Agents
Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock?
Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Lantheus (LNTH) and Vertex Pharmaceuticals (VRTX)
No Data